Effect of statin treatment in patients with acute myocardial infarction with prediabetes and type 2 diabetes mellitus

Studies comparing long-term clinical outcomes of statin treatment between acute myocardial infarction (AMI) patients with prediabetes and those type 2 diabetes mellitus (T2DM) after successful percutaneous coronary intervention (PCI) the newer-generation drug-eluting stents (DESs) are limited. We compared 2-year these patients. A total 11,962 AMI were classified as users (n = 10,243) nonusers 1719). Thereafter, further divided into normoglycemia, prediabetes, T2DM groups. The major outcome was occurrence adverse cardiac event (MACE) defined all-cause death, recurrent (Re-MI), or any repeat revascularization. After treatment, cumulative incidences MACE (P .314), death (CD), Re-MI, revascularization similar However, .025) .038) in group .001), .009), CD .048) significantly higher than normoglycemia group. Moreover, all 3 glycemic groups, MACE, among users. This study revealed that had worse comparable to treatment. studies warranted confirm current findings.